In a nutshell This study investigated the frequency and severity of oral mucositis (OM) in patients with colorectal cancer treated with chemotherapy and panitumumab (Vectibix) or cetuximab (Erbitux). Researchers suggested that panitumumab ?is associated with increased levels of OM in these patients. Some background Colorectal cancer is the fourth...
Read MoreOral mucositis caused by targeted therapy for colorectal cancer: which drug is safer?
